Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients

Cancer

Volumn 79, Issue 10, 1997, Pages 1879-1883

  Choi, Jin Hyuk ^a   Oh, Jee Young ^b   Ryu, Sung Ki ^b   Kim, Seung Jung ^b   Lee, Na Young ^b   Kim, Young Sun ^b   Yi, Sun Young ^b   Shim, Kang Sup ^b   Han, Woon Sup ^b  

^a Ajou University School of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

enzyme linked immunosorbent assay; epidermal growth factor receptor; gastric carcinoma; serum; tumor marker

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; STOMACH CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEX FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 1842410784     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1879::AID-CNCR6>3.0.CO;2-B     Document Type: Article

References (32)

1. Cohen S, Ushiro H, Stoscheck C, Chinkers M. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem 1982;257:1523-31.
2. Chen WS, Lazar CS, Poenie M, Tsien RY, Gill GN, Rosenfeld MG. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature 1987;328:820-3.
3. Todaro GJ, Fryling C, De Larco JE. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 1980;77:5258-62.
4. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987; 56:881-914.
5. Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1985;1:364-6.
6. Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JRC, et al. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1985;1:366-8.
7. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J. Schneider M, et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 1993;11:1873-8.
8. Santini J, Formento J-L, Francoual M, Milano G, Schneider M, Dassonville O, et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 1991;13:132-9.
9. Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN, Hennessy TPJ. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 1994;74:1693-8.
10. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987;55:513-6.
11. Volm M, Efferth T, Mattern J. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res 1992; 12:11-20.
12. Veale D, Kerr N, Gibson GJ, Kelly PJ, Harris AL. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer 1993;68:162-5.
13. Pfeiffer D, Stellwag B, Pfeiffer A, Borlinghaus P, Meier W, Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1989;33:146-50.
14. Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H, et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 1988;41:211-7.
15. Sugiyama K, Yonemura Y, Miyazaki I. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma. Cancer 1989;63:1557-61.
16. Yonemura Y, Takamura H, Ninomiya I, Fushida S, Tsugawa K, Kaji M, et al. Interrelationship between transforming growth factor-α and epidermal growth factor receptor in advanced gastric cancer. Oncology 1992;49:157-61.
17. Lee EY, Cibull ML, Strodel WE, Haley JV. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med 1994;118:235-9.
18. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 1994;25:968-81.
19. c-erB-2. Oncology 1995;52:385-91.
20. Iida A, Hirose K, Arai M, Yamaguchi A, Nakagawara G. Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer. Oncology 1995;52:189-95.
21. Livingstone JI, Yasui W, Tahara E, Wastell C. Are Japanese and European gastric cancer the same biological entity?: an immunohistochemical study. Br J Cancer 1995;72:976-80.
22. Partanen R, Hemminki K, Koskinen H, Luo J-C, Carney WP, Brandt-Rauf PW. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. J Occup Med 1994;36:1324-8.
23. Kim IS, Suh I, Oh HC, Kim BS, Lee Y. Incidence and survival of cancer in Kangwha County (1983-1987). Yonsei Med J 1989;30:256-68.
24. American Joint Committee on Cancer. Manual for staging of cancer. 4th edition Philadelphia: J.B. Lippincott, 1992:63-7.
25. Czerniak B, Herz F, Wersto RP, Alster P, Puszkin E, Schwarz E, et al. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. J Histochem Cytochem 1990;38:463-6.
26. Osaki T, Mitsudomi T, Oyama T, Nakanishi R, Yasumoto K. Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest 1995;108:157-62.
27. Leitzel K, Teramoto Y, Sampson E, Mauceri J, Langton BC, Demers L, et al. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J Clin Oncol 1992;10:1436-43.
28. Kandl H, Seymour L, Bezwoda WR. Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. Br J Cancer 1994;70:739-42.
29. Isola JJ, Holli K, Oksa H, Teramoto Y, Kallioniemi O-P. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer 1994;73:652-8.
30. Andersen TI, Paus E, Nesland JM, McKenzie SJ, Borresen A-L. Detection of c-erbB-2 related protein in sera from breast cancer patients. Acta Oncol 1995;34:499-504.
31. neu in human ovarian cancer. Cancer 1993;71:3942-6.
32. Okada N, Ohshio G, Yamaki K-I, Imamura T, Imamura M. Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: correlation to metastasis and shorter survival. Oncology 1995;52:392-6.